BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Sherry AD, Msaouel P, McCaw ZR, et al. (2023) Prevalence and implications of significance testing for baseline covariate imbalance in randomised cancer clinical trials: The Table 1 Fallacy. European Journal of Cancer (Oxford, England : 1990). 194: 113357 |
Rooney MK, Sharifi B, Ludmir EB, et al. (2023) Factors Associated With Altmetric Attention Scores for Randomized Phase III Cancer Clinical Trials. Jco Clinical Cancer Informatics. 7: e2300082 |
Sherry AD, Corrigan KL, Kouzy R, et al. (2023) Prevalence, trends, and characteristics of trials investigating local therapy in contemporary phase 3 clinical cancer research. Cancer |
Florez MA, Jaoude JA, Patel RR, et al. (2023) Incidence of Primary End Point Changes Among Active Cancer Phase 3 Randomized Clinical Trials. Jama Network Open. 6: e2313819 |
Das A, Lin TA, Lin C, et al. (2023) Assessment of Median and Mean Survival Time in Cancer Clinical Trials. Jama Network Open. 6: e236498 |
Corrigan KL, Kouzy R, Jaoude JA, et al. (2022) Inclusion of premenopausal women in breast cancer clinical trials. Breast (Edinburgh, Scotland). 66: 204-207 |
Diefenhardt M, Martin D, Ludmir EB, et al. (2022) Development and Validation of a Predictive Model for Toxicity of Neoadjuvant Chemoradiotherapy in Rectal Cancer in the CAO/ARO/AIO-04 Phase III Trial. Cancers. 14 |
Koay EJ, Zaid M, Aliru M, et al. (2022) Nab-Paclitaxel, Capecitabine, and Radiation Therapy Following Induction Chemotherapy in Treating Patients with Locally Advanced and Borderline Resectable Pancreatic Cancer: Phase I Trial and Imaging-based Biomarker Validation. International Journal of Radiation Oncology, Biology, Physics |
Bumanlag IM, Jaoude JA, Rooney MK, et al. (2022) Exclusion of Older Adults from Cancer Clinical Trials: Review of the Literature and Future Recommendations. Seminars in Radiation Oncology. 32: 125-134 |
Patel RR, Parisi R, Verma V, et al. (2022) Association between Prior Malignancy Exclusion Criteria and Age Disparities in Cancer Clinical Trials. Cancers. 14 |